Bulgaria to scrap all entry requirements against Covid-19 from May 1
Bulgaria to scrap all entry requirements against Covid-19 from May 1

Sofia, Bulgaria: The European nation recorded a total of 895 additional cases of the contagious COVID-19 mutant in the last 24 hours, as per the data shared in the unified information portal of April 19, 2022, an increase of 673 as compared to that of the previous day. This brings the total number of active COVID-19 cases in Bulgaria to 161,039. 

Along with this, twenty-six (26) patients with novel coronavirus lost their lives during the previous day, bringing the total number of the COVID-19 related fatalities to 36,810 as of April 19, 2022. 

Advertisement

Among the newly reported COVID-19 infections, 63.69% of them belonged to the unvaccinated population. Around 92.31% of the individuals who scummed to the COVID-19 mutant were not vaccinated against the mutant. 

With this, there are a total of 3290 patients with the COVID-19 virus who got recovered from the deadliest virus in the last 24 hours. With this, the overall number of the confirmed COVID-19 cases since the beginning of the COVID-19 pandemic in the Balkan state has increased to 952 493. 

For the present time, there are a total of 996 patients with the COVID-19 virus in Bulgaria, including the recently admitted 158 patients. Of the newly admitted into hospitals, 80.38% of the individuals were not vaccinated. Meanwhile, there are a total of 112 patients who are in intensive care units – ICU. 

During the time period last 24 hours, 1261 additional doses of the COVID-19 vaccines were administered in the country, as per the official data. 

Currently, there are a total of 2,053,896 Bulgarian nationals who are fully vaccinated by taking their required number of the COVID-19 vaccines, representing nearly 29.6% of the total targeted eligible population. 

On the other hand, there are a total of 738,989 individuals in Bulgaria who are fully vaccinated and have also taken their third dose, that is, booster shots of the COVID-19 vaccines.

 

ADV